• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织病理学亚型作为85例胸膜间皮瘤预后因素的相关方面。

Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas.

作者信息

Johansson L, Lindén C J

机构信息

Department of Pathology, University Hospital, Lund, Sweden.

出版信息

Chest. 1996 Jan;109(1):109-14. doi: 10.1378/chest.109.1.109.

DOI:10.1378/chest.109.1.109
PMID:8549169
Abstract

BACKGROUND

The prognosis of patients with pleural mesothelioma is more dependent on "pretreatment factors" than on the effect of therapeutic interventions. Histopathologic subtype is one of several important prognostic factors in pleural mesothelioma, and several studies indicate that the epithelial subtype of pleural mesotheliomas has a more favorable prognosis than the sarcomatoid. In this study, we retrospectively evaluated qualitative and quantitative aspects of the tissue specimens used for histopathologic diagnosis in 85 patients with pleural mesothelioma.

MATERIALS AND METHODS

The prognostic roles of two different histopathologic classification systems were evaluated in 85 consecutive cases of pleural mesotheliomas. Efficiency of different diagnostic procedures, influence of the size of the biopsy specimens on the histopathologic diagnosis, and immunohistochemical profiles for histopathologic subtypes of mesotheliomas were also evaluated.

RESULTS

Patients with pure epithelial mesotheliomas (n = 35), and especially those with the tubulopapillary subtype (n = 18) of epithelial mesotheliomas, survived significantly longer than those with a sarcomatoid component (n = 50). With larger biopsy specimens (surgical biopsy, autopsy), more tumors were classified as biphasic (36/78 vs 9/44, p < 0.005). The sarcomatoid mesotheliomas comprised about 20% of the tumors regardless of type of biopsy. Staining intensity for cytokeratin CAM 5.2 was equal in all types of mesotheliomas, while intensity with cytokeratin AE1/AE3 decreased from the epithelial to the sarcomatoid mesotheliomas. Staining with vimentin was most intense among the sarcomatoid mesotheliomas, while with epithelial membrane antigen it was most intense among the epithelial mesotheliomas.

CONCLUSIONS

The quality of the biopsy specimens has considerable impact on the possibility to arrive at a correct histopathologic diagnosis. Based on our results, we suggest tubulopapillary mesotheliomas be regarded as "low-grade mesotheliomas" and other types, including the epithelioid type of epithelial mesotheliomas, as "high-grade mesotheliomas." This should be taken into account when designing clinical trials.

摘要

背景

胸膜间皮瘤患者的预后更多地取决于“治疗前因素”,而非治疗干预的效果。组织病理学亚型是胸膜间皮瘤几个重要的预后因素之一,多项研究表明,胸膜间皮瘤的上皮亚型预后比肉瘤样亚型更有利。在本研究中,我们回顾性评估了85例胸膜间皮瘤患者用于组织病理学诊断的组织标本的定性和定量方面。

材料与方法

在85例连续的胸膜间皮瘤病例中评估了两种不同组织病理学分类系统的预后作用。还评估了不同诊断程序的效率、活检标本大小对组织病理学诊断的影响以及间皮瘤组织病理学亚型的免疫组化特征。

结果

纯上皮性间皮瘤患者(n = 35),尤其是那些具有上皮性间皮瘤管状乳头亚型(n = 18)的患者,存活时间明显长于具有肉瘤样成分的患者(n = 50)。活检标本较大(手术活检、尸检)时,更多肿瘤被分类为双相性(36/78 vs 9/44,p < 0.005)。无论活检类型如何,肉瘤样间皮瘤约占肿瘤的20%。细胞角蛋白CAM 5.2的染色强度在所有类型的间皮瘤中相同,而细胞角蛋白AE1/AE3的强度从上皮性间皮瘤到肉瘤样间皮瘤逐渐降低。波形蛋白染色在肉瘤样间皮瘤中最强,而上皮膜抗原染色在上皮性间皮瘤中最强。

结论

活检标本的质量对获得正确的组织病理学诊断的可能性有相当大的影响。根据我们的结果,我们建议将管状乳头间皮瘤视为“低级别间皮瘤”,将其他类型,包括上皮性间皮瘤的上皮样类型,视为“高级别间皮瘤”。在设计临床试验时应考虑到这一点。

相似文献

1
Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas.组织病理学亚型作为85例胸膜间皮瘤预后因素的相关方面。
Chest. 1996 Jan;109(1):109-14. doi: 10.1378/chest.109.1.109.
2
Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.肉瘤样间皮瘤与其他梭形细胞肿瘤的免疫组化鉴别
Am J Clin Pathol. 1989 Nov;92(5):566-71. doi: 10.1093/ajcp/92.5.566.
3
Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.肉瘤样间皮瘤及其组织学模拟物:一项比较性免疫组织化学研究。
Histopathology. 2003 Mar;42(3):270-9. doi: 10.1046/j.1365-2559.2003.01583.x.
4
The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.GATA 结合蛋白 3 在恶性胸膜间皮瘤诊断中的潜在应用。
Hum Pathol. 2020 Nov;105:1-8. doi: 10.1016/j.humpath.2020.08.005. Epub 2020 Sep 2.
5
Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma.七种单克隆抗体用于鉴别胸膜间皮瘤与肺腺癌的免疫组织化学评估
Cancer. 1991 Feb 1;67(3):655-62. doi: 10.1002/1097-0142(19910201)67:3<655::aid-cncr2820670322>3.0.co;2-j.
6
New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center.双相性间皮瘤诊断可重复性的新见解:来自 MESOPATH 参考中心的国际间皮瘤专家组的多机构评估。
J Thorac Oncol. 2018 Aug;13(8):1189-1203. doi: 10.1016/j.jtho.2018.04.023. Epub 2018 Apr 30.
7
Unusual intraparenchymal growth patterns of malignant pleural mesothelioma.恶性胸膜间皮瘤不寻常的实质内生长模式。
Histopathology. 2003 Feb;42(2):150-5. doi: 10.1046/j.1365-2559.2003.01555.x.
8
The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.胸膜肉瘤样间皮瘤与肺梭形细胞/多形性(肉瘤样)癌的鉴别诊断:国际间皮瘤小组和MESOPATH国家参考中心的循证指南
Hum Pathol. 2017 Sep;67:160-168. doi: 10.1016/j.humpath.2017.07.015. Epub 2017 Aug 4.
9
Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.碳酸酐酶 IX(CAIX)在恶性间皮瘤中的表达。免疫组织化学和免疫细胞化学研究。
Neoplasma. 2014;61(2):161-9. doi: 10.4149/neo_2014_031.
10
Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma.多形性上皮样弥漫性恶性胸膜间皮瘤:临床病理回顾和重新分类为双相或肉瘤样间皮瘤的概念建议。
J Thorac Oncol. 2011 May;6(5):896-904. doi: 10.1097/JTO.0b013e318211127a.

引用本文的文献

1
Reflecting real-world patients with mesothelioma in research: an interim report of baseline characteristics from the ASSESS-meso cohort.在研究中反映间皮瘤真实世界患者情况:来自ASSESS-meso队列的基线特征中期报告。
ERJ Open Res. 2023 Dec 27;9(6). doi: 10.1183/23120541.00467-2023. eCollection 2023 Nov.
2
Malignant peritoneal mesothelioma: correlation between CT imaging features and histologic subtypes.恶性腹膜间皮瘤:CT影像特征与组织学亚型之间的相关性
Abdom Radiol (NY). 2021 Nov;46(11):5105-5113. doi: 10.1007/s00261-021-03231-4. Epub 2021 Aug 3.
3
Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma.
弥漫性恶性胸膜间皮瘤患者活检采样预测组织学的诊断价值。
Cancer. 2019 Dec 1;125(23):4164-4171. doi: 10.1002/cncr.32416. Epub 2019 Aug 7.
4
Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的早期临床特征
In Vivo. 2018 Sep-Oct;32(5):1169-1174. doi: 10.21873/invivo.11360.
5
Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma.靶向微小RNA以改善恶性间皮瘤的诊断和治疗方法。
Oncotarget. 2017 Aug 24;8(44):78193-78207. doi: 10.18632/oncotarget.20409. eCollection 2017 Sep 29.
6
Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?恶性间皮瘤、BAP1 免疫组化和 VEGFA:BAP1 是否具有早期诊断和评估预后的潜力?
Dis Markers. 2017;2017:1310478. doi: 10.1155/2017/1310478. Epub 2017 Sep 11.
7
Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease.分子谱分析显示原发性间皮瘤细胞系可重现人类疾病。
Cell Death Differ. 2016 Jul;23(7):1152-64. doi: 10.1038/cdd.2015.165. Epub 2016 Feb 19.
8
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma.索拉非尼和依维莫司联合用药在恶性胸膜间皮瘤的临床前模型中显示出抗肿瘤活性。
BMC Cancer. 2015 May 8;15:374. doi: 10.1186/s12885-015-1363-1.
9
Pleural mesothelioma: an institutional experience of 66 cases.胸膜间皮瘤:66例病例的机构经验
Korean J Pathol. 2014 Apr;48(2):91-9. doi: 10.4132/KoreanJPathol.2014.48.2.91. Epub 2014 Apr 28.
10
Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma.腹膜间皮瘤中 Ki-67 和性激素受体在性别间的差异表达。
Pathol Oncol Res. 2009 Dec;15(4):671-8. doi: 10.1007/s12253-009-9170-0. Epub 2009 Apr 29.